Publication Name	World Journal of Hepatology
Manuscript ID	45521
Country	United States

Received	2019-01-10 01:57
Peer-Review Started	2019-01-10 06:56
To Make the First Decision	2019-02-18 01:46
Return for Revision	2019-03-05 01:41
Revised	2019-03-22 17:12
Second Decision	2019-04-04 07:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2019-04-08 17:58
Articles in Press	2019-04-08 17:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-04-24 05:51
Publish the Manuscript Online	2019-04-26 03:40

ISSN	1948-5182 (online)
Open Access
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
Manuscript Source	Unsolicited Manuscript
All Author List	Jason Yerke, Seth Bauer, Stephanie Bass, Heather Torbic, Michael Militello, Erin Roach, Ibrahim A Hanouneh and Sarah Welch
ORCID	Author(s) ORCID Number Jason Yerke http://orcid.org/0000-0002-4391-9645 Seth Bauer http://orcid.org/0000-0002-0420-0320 Stephanie Bass http://orcid.org/0000-0001-5175-0459 Heather Torbic http://orcid.org/0000-0002-1961-4104 Michael Militello http://orcid.org/0000-0001-5311-1669 Erin Roach http://orcid.org/0000-0003-1504-7808 Ibrahim A Hanouneh http://orcid.org/0000-0003-1336-1756 Sarah Welch http://orcid.org/0000-0003-2127-5997
Funding Agency and Grant Number
Corresponding Author	Jason Yerke, PharmD, Pharmacist, Department of Pharmacy, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States. yerkej@ccf.org
Key Words	Fibrosis; Venous thromboembolism; Venous thrombosis; Liver; Embolism
Core Tip	While patients with cirrhosis have historically been considered to be coagulpathic, recent data suggests that these patients may be both hypo- and hypercoagulable. Recommendation for provision of chemoprophylaxis to prevent venous thromboembolism (VTE) in this group of patients is lacking. In our study, pharmacological VTE prophylaxis decreased composite rates of major bleeding and VTE but was not protective against VTE, further demonstrating the uncertain utility of chemoprophylaxis in this population.
Publish Date	2019-04-26 03:40
Citation	Yerke J, Bauer S, Bass S, Torbic H, Militello M, Roach E, Hanouneh I, Welch S. Effectiveness of venous thromboembolism prophylaxis in patients with liver disease. World J Hepatol 2019; 11(4): 379-390
URL	https://www.wjgnet.com/1948-5182/full/v11/i4/379.htm
DOI	https://dx.doi.org/10.4254/wjh.v11.i4.379

Full Article (PDF)	WJH-11-379.pdf
Full Article (Word)	WJH-11-379.docx
Manuscript File	45521-Review.docx
Answering Reviewers	45521-Answering reviewers.pdf
Audio Core Tip	45521-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	45521-Conflict-of-interest statement.pdf
Copyright License Agreement	45521-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	45521-Grant application form(s).pdf
Institutional Review Board Approval Form or Document	45521-Institutional review board statement.pdf
Peer-review Report	45521-Peer-review(s).pdf
Scientific Misconduct Check	45521-Scientific misconduct check.pdf
Scientific Editor Work List	45521-Scientific editor work list.pdf
CrossCheck Report	45521-CrossCheck Report.pdf